Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia
Top Cited Papers
Open Access
- 31 May 2011
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 377 (9781), 1929-1937
- https://doi.org/10.1016/s0140-6736(11)60394-2
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Regenerative Therapy in Peripheral Artery DiseaseCardiovascular Therapeutics, 2009
- Human Studies of Angiogenic Gene TherapyCirculation Research, 2009
- Local Gene Transfer and Expression Following Intramuscular Administration of FGF-1 Plasmid DNA in Patients With Critical Limb IschemiaMolecular Therapy, 2009
- Gene therapy as a novel therapeutic option in the treatment of peripheral vascular disease: systematic review and meta-analysisInternational Journal of Clinical Practice, 2008
- Therapeutic Angiogenesis With Intramuscular NV1FGF Improves Amputation-free Survival in Patients With Critical Limb IschemiaMolecular Therapy, 2008
- Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)Journal of Vascular Surgery, 2007
- Pathophysiology of Critical Limb IschemiaPublished by Elsevier BV ,2006
- Management of Peripheral Vascular DiseaseAnnual Review of Medicine, 2005
- Human FGF‐1 gene transfer promotes the formation of collateral vessels and arterioles in ischemic muscles of hypercholesterolemic hamstersThe Journal of Gene Medicine, 2004
- MEASUREMENT OF PAINSurgical Clinics of North America, 1999